See how seamless collaboration and human-centered design create a first-of-its-kind, proprietary, needle-free continuous glucose monitor (CGM) that integrates sophisticated technology with advanced biosensors and algorithms.

In collaboration with Ascendis Pharma, Phillips-Medisize was recently recognized with a third prestigious award for the SKYTROFA Auto-Injector.

Our Aria smart autoinjector is a powerful, flexible, platform, designed for ease of use with a compact form and aligned to key emerging global trends.

A familiar, state-of-the-art design in a market-ready, scalable platform for fast, high-volume rollout of novel or generic drug treatments.

Discover how the initial 23,000 square meters of manufacturing space in Katowice will serve as a strategically centralized European location—offering expansive production capabilities, facilitating timely product delivery and creating hundreds of skilled new jobs.

Designing, producing and delivering a commercially available medical product is incredibly challenging—especially when that product is a drug delivery device. Request our whitepaper for actionable insights that support your market success.

-Read the article published by LifeSciencesIntelligence to learn why Phillips-Medisize recently received its third industry award for a uniquely designed drug delivery device. The auto-injector is a dual-chamber, automatic, reusable device for pediatric patients with growth hormone deficiency.

Medical device design is quickly evolving with the introduction of advanced dual chamber systems and pre-filled syringes supporting patient self-administration. Explore how “Design Improvements Aid Self-medication of Lyophilised Drugs” with our Commercial Directors, Tony Bedford and Iain Simpson.

Don’t miss this special feature that spotlights our Aria Smart Autoinjector. As you plan new drug delivery innovations, explore methods of “Designing in Sustainability, Usability & Digitization for Patient Compliance.”